Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilmar Weinmann

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Organic Chemistry|June 11, 2008
Synthesis of 7a-substituted Hajos-Wiechert ketone analoguesJason W J Kennedy, Sophia Vietrich, Hilmar Weinmann, et al.
Angewandte Chemie (International Ed. in English)|March 27, 2025
Chemical Process Development in the Pharmaceutical Industry in Europe-Insights and Perspectives from Industry ScientistsJoachim Krueger, André P Dieskau, Jorma Hassfeld, et al.
Journal of Medicinal Chemistry|November 1, 2019
Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in VivoLars Wortmann, Bernhard Lindenthal, Peter Muhn, et al.
Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.
Journal of Medicinal Chemistry|April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2Erik Eggert, Roman C Hillig, Silke Koehr, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
ACS Chemical Biology|October 19, 2017
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of ActionAmaury E Fernández-Montalván, Markus Berger, Benno Kuropka, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Organic Chemistry|June 11, 2008
Synthesis of 7a-substituted Hajos-Wiechert ketone analoguesJason W J Kennedy, Sophia Vietrich, Hilmar Weinmann, et al.
Angewandte Chemie (International Ed. in English)|March 27, 2025
Chemical Process Development in the Pharmaceutical Industry in Europe-Insights and Perspectives from Industry ScientistsJoachim Krueger, André P Dieskau, Jorma Hassfeld, et al.
Journal of Medicinal Chemistry|November 1, 2019
Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in VivoLars Wortmann, Bernhard Lindenthal, Peter Muhn, et al.
Bioconjugate Chemistry|June 6, 2022
A Novel NAMPT Inhibitor-Based Antibody-Drug Conjugate Payload Class for Cancer TherapyNiels Böhnke, Markus Berger, Nils Griebenow, et al.
Journal of Medicinal Chemistry|April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2Erik Eggert, Roman C Hillig, Silke Koehr, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
ACS Chemical Biology|October 19, 2017
Isoform-Selective ATAD2 Chemical Probe with Novel Chemical Structure and Unusual Mode of ActionAmaury E Fernández-Montalván, Markus Berger, Benno Kuropka, et al.
Pageof 2